The effect of KY1005-2D10 in the human skin transplant model of psoriasis.

Completed

• Conditions: 10014982; psoriasis

• Registration Number: NL-OMON42911
• Lead Sponsor: Derphartox

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 14

Inclusion Criteria

Patients with moderate to severe psoriasis

Exclusion Criteria

Volunteers undergoing UV/light therapy or taking systemic drugs such as cyclosporin A or methotrexate
Volunteers using local topical corticosteroids
Volunteers developing psoriasis at wound sites (Köbner phenomenon)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Effect on typical psoriasis skin features after treatment with KY1005-2D10.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>